The State Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Mental Health Institute, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Sci Rep. 2017 Mar 10;7:44155. doi: 10.1038/srep44155.
Autism spectrum disorder (ASD) describes a group of neurodevelopmental disorders with high heritability, although the underlying genetic determinants of ASDs remain largely unknown. Large-scale whole-genome studies of copy number variation in Han Chinese samples are still lacking. We performed a genome-wide copy number variation analysis of 343 ASD trios, 203 patients with sporadic cases and 988 controls in a Chinese population using Illumina genotyping platforms to identify CNVs and related genes that may contribute to ASD risk. We identified 32 rare CNVs larger than 1 Mb in 31 patients. ASD patients were found to carry a higher global burden of rare, large CNVs than controls. Recurrent de novo or case-private CNVs were found at 15q11-13, Xp22.3, 15q13.1-13.2, 3p26.3 and 2p12. The de novo 15q11-13 duplication was more prevalent in this Chinese population than in those with European ancestry. Several genes, including GRAMD2 and STAM, were implicated as novel ASD risk genes when integrating whole-genome CNVs and whole-exome sequencing data. We also identified several CNVs that include known ASD genes (SHANK3, CDH10, CSMD1) or genes involved in nervous system development (NYAP2, ST6GAL2, GRM6). Besides, our study also implicated Contactins-NYAPs-WAVE1 pathway in ASD pathogenesis. Our findings identify ASD-related CNVs in a Chinese population and implicate novel ASD risk genes and related pathway for further study.
自闭症谱系障碍(ASD)描述了一组具有高遗传性的神经发育障碍,尽管 ASDs 的潜在遗传决定因素在很大程度上仍不清楚。在汉族人群中,仍缺乏大规模全基因组拷贝数变异的研究。我们使用 Illumina 基因分型平台,对 343 个 ASD 三核苷酸、203 个散发性病例和 988 个对照进行了全基因组拷贝数变异分析,以鉴定可能导致 ASD 风险的 CNVs 和相关基因。我们在 31 名患者中发现了 32 个大于 1Mb 的罕见 CNVs。与对照组相比,ASD 患者携带罕见、大片段 CNVs 的全球负担更高。在 15q11-13、Xp22.3、15q13.1-13.2、3p26.3 和 2p12 上发现了新发或病例特异性的 CNVs。新发的 15q11-13 重复在本中国人群中的发生率高于欧洲血统人群。整合全基因组 CNVs 和全外显子组测序数据后,包括 GRAMD2 和 STAM 在内的几个基因被认为是新的 ASD 风险基因。我们还发现了几个包含已知 ASD 基因(SHANK3、CDH10、CSMD1)或参与神经系统发育的基因(NYAP2、ST6GAL2、GRM6)的 CNVs。此外,我们的研究还暗示了 Contactins-NYAPs-WAVE1 通路与 ASD 的发病机制有关。我们的研究结果确定了中国人群中与 ASD 相关的 CNVs,并暗示了新的 ASD 风险基因和相关通路,以进一步研究。